Whitney Richards

Nanomix, Inc. provides nano technology solutions. It is a nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. The firm's nanoscale electronic sensors have enabled the development of the next generation of Point of Care testing systems that can be used in any setting. The company's mobile diagnostic platform performs multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample. Nanomix was founded by Alexander Zettl and Marvin L. Cohen in September 2000 and is headquartered in Emeryville, CA.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

First Light Diagnostics, Inc. develops automated medical diagnostic products for the detection of microbes that cause healthcare and hospital infections. The firm offers MultiPath technology detects and counts fluorescent targets without using magnification. Its MultiPath technology is used for screening, blood infections, surgical infections, skin infections and GI infections. The company was founded by Donald Straus and is headquartered in Bedford, MA.